Novel PTSD Treatment Improved Symptom Severity in Phase IIb Trial
MedPage Today) — An investigational therapy for post-traumatic stress disorder (PTSD) improved symptom severity as soon as one month into a 12-week, phase IIb study. In a modified intent-to-treat analysis of 182 patients, treatment effects with…
Read More
Recent Comments